Nima Nabavizadeh1, David A Elliott2, Yiyi Chen3, Aaron S Kusano4, Timur Mitin2, Charles R Thomas2, John M Holland2. 1. Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon. Electronic address: nabaviza@ohsu.edu. 2. Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon. 3. Division of Biostatistics, Department of Public Health and Preventative Medicine, Oregon Health & Science University, Portland, Oregon. 4. Department of Radiation Oncology, University of Washington, Seattle, Washington.
Abstract
PURPOSE: To survey image guided radiation therapy (IGRT) practice patterns, as well as IGRT's impact on clinical workflow and planning treatment volumes (PTVs). METHODS AND MATERIALS: A sample of 5979 treatment site-specific surveys was e-mailed to the membership of the American Society for Radiation Oncology (ASTRO), with questions pertaining to IGRT modality/frequency, PTV expansions, method of image verification, and perceived utility/value of IGRT. On-line image verification was defined as images obtained and reviewed by the physician before treatment. Off-line image verification was defined as images obtained before treatment and then reviewed by the physician before the next treatment. RESULTS: Of 601 evaluable responses, 95% reported IGRT capabilities other than portal imaging. The majority (92%) used volumetric imaging (cone-beam CT [CBCT] or megavoltage CT), with volumetric imaging being the most commonly used modality for all sites except breast. The majority of respondents obtained daily CBCTs for head and neck intensity modulated radiation therapy (IMRT), lung 3-dimensional conformal radiation therapy or IMRT, anus or pelvis IMRT, prostate IMRT, and prostatic fossa IMRT. For all sites, on-line image verification was most frequently performed during the first few fractions only. No association was seen between IGRT frequency or CBCT utilization and clinical treatment volume to PTV expansions. Of the 208 academic radiation oncologists who reported working with residents, only 41% reported trainee involvement in IGRT verification processes. CONCLUSION: Consensus guidelines, further evidence-based approaches for PTV margin selection, and greater resident involvement are needed for standardized use of IGRT practices.
PURPOSE: To survey image guided radiation therapy (IGRT) practice patterns, as well as IGRT's impact on clinical workflow and planning treatment volumes (PTVs). METHODS AND MATERIALS: A sample of 5979 treatment site-specific surveys was e-mailed to the membership of the American Society for Radiation Oncology (ASTRO), with questions pertaining to IGRT modality/frequency, PTV expansions, method of image verification, and perceived utility/value of IGRT. On-line image verification was defined as images obtained and reviewed by the physician before treatment. Off-line image verification was defined as images obtained before treatment and then reviewed by the physician before the next treatment. RESULTS: Of 601 evaluable responses, 95% reported IGRT capabilities other than portal imaging. The majority (92%) used volumetric imaging (cone-beam CT [CBCT] or megavoltage CT), with volumetric imaging being the most commonly used modality for all sites except breast. The majority of respondents obtained daily CBCTs for head and neck intensity modulated radiation therapy (IMRT), lung 3-dimensional conformal radiation therapy or IMRT, anus or pelvis IMRT, prostate IMRT, and prostatic fossa IMRT. For all sites, on-line image verification was most frequently performed during the first few fractions only. No association was seen between IGRT frequency or CBCT utilization and clinical treatment volume to PTV expansions. Of the 208 academic radiation oncologists who reported working with residents, only 41% reported trainee involvement in IGRT verification processes. CONCLUSION: Consensus guidelines, further evidence-based approaches for PTV margin selection, and greater resident involvement are needed for standardized use of IGRT practices.
Authors: Randy L Wei; Malcolm D Mattes; James Yu; Adrienne Thrasher; Hui-Kuo Shu; Harald Paganetti; Jennifer De Los Santos; Bridget Koontz; Christopher Abraham; Tracy Balboni Journal: Pract Radiat Oncol Date: 2016-09-07
Authors: Lindsay S Rowe; Jeremy J Mandia; Kilian E Salerno; Uma T Shankavaram; Shaoli Das; Freddy E Escorcia; Holly Ning; Deborah E Citrin Journal: Adv Radiat Oncol Date: 2022-02-03
Authors: Anne Richter; Bülent Polat; Ingulf Lawrenz; Stefan Weick; Otto Sauer; Michael Flentje; Frederick Mantel Journal: Radiat Oncol Date: 2016-11-08 Impact factor: 3.481